Filing Details
- Accession Number:
- 0001140361-15-025489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-26 08:30:30
- Reporting Period:
- 2015-06-25
- Filing Date:
- 2015-06-26
- Accepted Time:
- 2015-06-26 08:30:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1572552 | Asterias Biotherapeutics Inc. | AST | Biological Products, (No Disgnostic Substances) (2836) | 461047971 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1229339 | D Alfred Kingsley | 150 E. 57Th Street New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Series A Common Stock | Acquisiton | 2015-06-25 | 5,000 | $4.32 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.25 to $4.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by him at each separate price on each date of sale.